When Access Creates Evidence: Real-World Data from Expanded Access Programs

• Real-world evidence generated through EAPs that has informed regulatory decisionmaking, contributing to EMA scientific advice discussions and, in specific cases, resulted in FDA labeling indications and marketing authorizations
• This session will focus on the types of approaches and real regulatory results

Speakers:

Anne B. Cropp

Chief Scientific Officer

Early Access Care